Project Grant R43DA064719
Award Date 6/1/26
Completion Date 5/31/27
Dollars Obligated $314K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75215, USA
Similar Awards
- Federal Grant Award Summary Taesun, LLC received a $610,738 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on August 1, 2025, with completion anticipated by August 31, 2026. The award supports the development of a streamlined fentanyl testing device that integrates fentanyl test strips (FTS) with sample preparation capabilities—specifically combining crushing, measuring, and assaying functions into a single,...
- Federal Grant Award Summary Carina Medical LLC received a $304,215 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025 and concluding July 31, 2026. The awardee is developing and validating a novel software platform designed to enable decentralized clinical trials (DCTs) for substance use disorder (SUD) research, with integration of large language models (LLMs). This platform addresses significant...
- Federal Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and refine a medication adherence and monitoring system for decentralized clinical trials in substance use disorder (SUD) treatment. The primary deliverable is an adapted version of Addinex's existing medication management platform that enables at-home medication dispensing...
- Federal Grant Award Summary Jillion Therapeutics Inc. received a Phase I Small Business Innovation Research (SBIR) Project Grant of $398,093 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), with an award date of July 1, 2025 and completion date of June 30, 2027. The company will utilize its proprietary DNA-Encoded Library (DEL) drug discovery platform to identify drug-like compounds that bind to GPR37, an orphan G-protein...
- Federal Grant Award Summary Princeton University received a $164,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 15, 2025, with completion targeted for July 31, 2027. The award supports development of a Chemical Artificial Intelligence (AI) and Data Science Platform designed to identify and discover novel psychoactive substances (NPS). The project will deliver three primary products: (1) a...
- Federal Grant Award Summary Rescue Biomedical, LLC received a $799,430 Phase I Small Business Innovation Research (SBIR) grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period August 1, 2025, through July 31, 2026. The award funds development and commercialization of the Automatic Detection Device (AD2), a user-centric wearable detection module designed to identify opioid-induced respiratory depression. The AD2 serves as...
- Federal Grant Award Summary Biomotivate LLC received a $613,744 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to support individuals with opioid use disorders (OUDs). The award, issued August 1, 2025, with completion targeted for July 31, 2026, funds the creation of a novel digital...
- Federal Project Grant Award Summary Praeventix LLC received a $355,190 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period of June 1, 2026 through May 31, 2027. The award supports in vivo preclinical research characterizing 5-HT7 (serotonin 7 receptor) modulators in rat models of opioid use disorder (OUD). The research program will evaluate the impact of novel 5-HT7 antagonists, including the lead...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $159,615 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025, for research extending through June 30, 2027. This K99/R00 award supports a research initiative titled "Predicting Craving and Relapse Using Neurobehavioral Markers of Goals and Habits in Opioid Use Disorder." The project delivers longitudinal neurobehavioral...
- This $586,936 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a low-cost, disposable urine test strip that can rapidly and quantitatively measure substance use disorder (SUD) medication drugs and their metabolites. The award recipient, Vitan-Biotech LLC, will create a point-of-use lateral flow assay (LFA) test strip that leverages innovative signal amplification technology to...